This webinar, presented by Olivier Barberan, Director, Translational Medicine Solutions at Elsevier will cover tools and best practices when using a static approach to DDI predictions to support drug submission and labeling.

Topics to be covered:
• Regulatory guidance to predict DDI (FDA, EMA, DMDA)
• Types of questions asked by regulatory agencies and how to answer them
• Use, added value and limitation of mechanistic approach and PB/PK during drug development

The format of this webinar will be a 35 minute presentation followed by a Q&A session

Part of the PharmaPendium Webinar Series: Risk Assessment in Drug Development
Olivier Barberan
Director, Translational Medicine Solutions , Elsevier
Register To Watch Recording
Full name*
Email Address*
Job Title*
Which gender do you most identify with
Marketing Permission
Elsevier (https://www.elsevier.com/about/locations) may send you information about relevant products and events. If you are happy to receive such messages, please tick the box below We will not share or sell your personal information. You can unsubscribe anytime by clicking the unsubscribe link in the footer of our emails, or by r visiting the Elsevier Preference center and updating your communication preferences. For more information, please read our privacy policy.
Yes, I consent to receiving emails